These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Minimize the use of minimization with unequal allocation. Proschan M; Brittain E; Kammerman L Biometrics; 2011 Sep; 67(3):1135-41. PubMed ID: 21281276 [TBL] [Abstract][Full Text] [Related]
43. Standards for design and measurement would make clinical research reproducible and usable. Dickersin K; Mayo-Wilson E Proc Natl Acad Sci U S A; 2018 Mar; 115(11):2590-2594. PubMed ID: 29531086 [TBL] [Abstract][Full Text] [Related]
44. [Design consideration for clinical trials]. Flemming TR Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):568-73. PubMed ID: 3355178 [No Abstract] [Full Text] [Related]
45. Methodology standards associated with quality reporting in clinical studies in pediatric surgery journals. Thakur A; Wang EC; Chiu TT; Chen W; Ko CY; Chang JT; Atkinson JB; Fonkalsrud EW; Grosfeld JL J Pediatr Surg; 2001 Aug; 36(8):1160-4. PubMed ID: 11479847 [TBL] [Abstract][Full Text] [Related]
46. Incorporating ethical principles into clinical research protocols: a tool for protocol writers and ethics committees. Li RH; Wacholtz MC; Barnes M; Boggs L; Callery-D'Amico S; Davis A; Digilova A; Forster D; Heffernan K; Luthin M; Lynch HF; McNair L; Miller JE; Murphy J; Van Campen L; Wilenzick M; Wolf D; Woolston C; Aldinger C; Bierer BE J Med Ethics; 2016 Apr; 42(4):229-34. PubMed ID: 26811365 [TBL] [Abstract][Full Text] [Related]
48. A clinical protocol for the study of traditional medicine and human immunodeficiency virus-related illness. Chaudhury RR J Altern Complement Med; 2001 Oct; 7(5):553-66. PubMed ID: 11719948 [No Abstract] [Full Text] [Related]
49. Meta-analysis of randomized clinical trials in cancer. Buyse M Gan To Kagaku Ryoho; 1993 Dec; 20(16):2501-6. PubMed ID: 8279848 [No Abstract] [Full Text] [Related]
51. Data Monitoring Committees and early stopping guidelines: the Southwest Oncology Group experience. Crowley J; Green S; Liu PY; Wolf M Stat Med; 1994 Jul 15-30; 13(13-14):1391-9. PubMed ID: 7973218 [TBL] [Abstract][Full Text] [Related]
52. Ethics in phase II trials of cancer therapies. Davis M Perspectives Prof; 2000; 20(1):E1. PubMed ID: 15115038 [No Abstract] [Full Text] [Related]
53. Trends in the number and the quality of trial protocols involving children submitted to a French Institutional Review Board. Gautier I; Janiaud P; Rollet N; André N; Tsimaratos M; Cornu C; Malik S; Gentile S; Kassaï B BMC Med Res Methodol; 2017 Aug; 17(1):130. PubMed ID: 28835231 [TBL] [Abstract][Full Text] [Related]
54. [Biomedical research and Huriet's law: revival or recession of clinical research?]. Calès P Gastroenterol Clin Biol; 1991; 15(6-7):471-5. PubMed ID: 1916123 [No Abstract] [Full Text] [Related]
56. Human subject research, ethics and the developing world. Moazam F J Pak Med Assoc; 2000 Nov; 50(11):388-93. PubMed ID: 11126817 [No Abstract] [Full Text] [Related]
57. Another STEPP in the right direction. Bonetti M; Cole BF; Gelber RD J Clin Oncol; 2008 Aug; 26(22):3813-4; author reply 3814-5. PubMed ID: 18669475 [No Abstract] [Full Text] [Related]
58. Variability among institutional review boards and the value of local research context. Clark DC Crit Care Med; 2001 Feb; 29(2):444-5. PubMed ID: 11246330 [No Abstract] [Full Text] [Related]
59. The role of the nurse in clinical cancer research. Cassidy J; Macfarlane DK Cancer Nurs; 1991 Jun; 14(3):124-31. PubMed ID: 2059955 [TBL] [Abstract][Full Text] [Related]
60. Adherence to research protocols in a clinical context: challenges and recommendations from behavioral intervention trials. Johnson MO; Remien RH Am J Psychother; 2003; 57(3):348-60. PubMed ID: 12961819 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]